You are here

  • Home
  • Archive
  • Volume 60, Issue Suppl 1
  • FRI0037 Results of a pivotal (phase iii) placebo and active comparator controlled efficacy trial of rofecoxib 25 and 50 mg in adult patients with rheumatoid arthritis (ra)

Alerts

Article menu
Download PDFPDF
Speaker abstracts 2001
Rheumatoid Arthritis – Treatment
FRI0037 Results of a pivotal (phase iii) placebo and active comparator controlled efficacy trial of rofecoxib 25 and 50 mg in adult patients with rheumatoid arthritis (ra)
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address